() Norfenicol Injection | Norbrook Laboratories

Norfenicol Injection

Norfenicol Injection is an antimicrobial solution for injection containing florfenicol. It is indicated to treat respiratory tract infections in cattle and acute outbreaks of respiratory disease in pigs.

Target Species: Beef cattle, dairy cattle, pigs

  • Active Ingredient

    Each ml contains: Florfenicol 300 mg

  • Pharmaceutical Form

    Solution for Injection. A light yellow to straw coloured solution.

  • Indications

    Cattle: Treatment of respiratory tract infections in clinically diseased cattle due to Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, susceptible to Florfenicol. Swine: Treatment of acute outbreaks of respiratory disease caused by strains of Actinobacillus pleuropneumoniae and Pasteurella multocida susceptible to Florfenicol.

  • Dosage

    To ensure correct dosage body weight should be determined as accurately as possible. Swab septum before removing each dose. Use a dry sterile needle and syringe. Do not broach the vial more than 25 times. Cattle: Intramuscular Injection: 20 mg/kg bodyweight (1 ml/15 kg) to be administered twice 48 hours apart using a 16-gauge needle. Subcutaneous Injection: 40 mg/kg bodyweight (2 ml/15 kg) to be administered once only using a 16-gauge needle. The dose volume given at any one injection site should not exceed 10 ml. The injection should only be given in the neck. Pigs: Intramuscular Injection: 15 mg/kg bodyweight (1 ml per 20 kg) into the neck muscle twice at 48 hour intervals using a 16-gauge needle. The volume administered per injection site should not exceed 3 ml. It is recommended to treat cattle and swine in the early stages of disease and to evaluate the response to treatment within 48 hours after the second injection. If clinical signs of respiratory disease persist 48 hours after the last injection, treatment should be changed using another formulation or another antibiotic and continued until clinical signs have resolved.

Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.

Prefer to speak directly to a member of our team?

Norbrook MENA 

All enquiries for the MENA team are manged by the Norbrook Head Office in Northern Ireland 

We are open Mon - Fri 9:00am - 5:00pm